TC BioPharm (Holdings) (FRA:T0U) PB Ratio: 22.60 (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:T0U TC BioPharm (Holdings) PLC FRA:T0U
17 GF Score
Price €132.00
View Full Analysis

What is TC BioPharm (Holdings) PB Ratio?

TC BioPharm (Holdings) FRA:T0U 17 PB Ratio is 22.60 as of Jul. 15, 2026. GuruFocus rates FRA:T0U with a GF Score™ of 17/100.

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-15), TC BioPharm (Holdings)'s share price is €132.00. TC BioPharm (Holdings)'s Book Value per Share for the quarter that ended in Dec. 2024 was €5.84. Hence, TC BioPharm (Holdings)'s PB Ratio of today is 22.60.

The historical rank and industry rank for TC BioPharm (Holdings)'s PB Ratio or its related term are showing as below:

FRA:T0U's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.895
* Ranked among companies with meaningful PB Ratio only.

Back to Basics: PB Ratio

TC BioPharm (Holdings)  (FRA:T0U) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

TC BioPharm (Holdings) PB Ratio Related Terms

TC BioPharm (Holdings) PB Ratio Historical Data

* Premium members only.

The historical data trend for TC BioPharm (Holdings)'s PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TC BioPharm (Holdings) PB Ratio Chart

TC BioPharm (Holdings) Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
PB Ratio
Get a 7-Day Free Trial 0.00 0.00 24.69 0.76 22.60

TC BioPharm (Holdings) Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.69 1.35 0.76 1.53 22.60

FRA:T0U vs SIGY, CNBX, SYGGF: PB Ratio Comparison

For the Biotechnology subindustry, TC BioPharm (Holdings)'s PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TC BioPharm (Holdings) PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TC BioPharm (Holdings)'s PB Ratio distribution charts can be found below:

* The bar in red indicates where TC BioPharm (Holdings)'s PB Ratio falls into.


FRA:T0U
17GF Score
TC BioPharm (Holdings) PLC FRA:T0U
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TC BioPharm (Holdings) PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

TC BioPharm (Holdings)'s PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=132.00/5.842
=22.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PB Ratio=Market Cap /(Total Stockholders Equity-Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Frequently Asked Questions Learn more about PB Ratio →
What does a PB Ratio of 22.60 mean?
TC BioPharm (Holdings) (FRA:T0U) has a PB Ratio of 22.60 as of Jul. 15, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on TC BioPharm (Holdings) and its competitors.
Is TC BioPharm (Holdings)'s PB Ratio too high?
TC BioPharm (Holdings)'s current PB Ratio is 22.60. The Biotechnology industry median PB Ratio is 2.90. TC BioPharm (Holdings)'s value of 22.60 is 680.7% above this industry median. Overall, TC BioPharm (Holdings) has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does TC BioPharm (Holdings)'s PB Ratio compare to SIGY and CNBX?
TC BioPharm (Holdings)'s PB Ratio of 22.60 can be compared against companies in the Biotechnology industry. The industry median PB Ratio is 2.90. TC BioPharm (Holdings)'s value of 22.60 is 680.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.90, based on 1,228 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TC BioPharm (Holdings)'s current PB Ratio of 22.60 is 680.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on TC BioPharm (Holdings) and its competitors. For the Biotechnology industry, the median PB Ratio is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TC BioPharm (Holdings)'s current PB Ratio is 22.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TC BioPharm (Holdings) stock overvalued right now?
TC BioPharm (Holdings) (FRA:T0U) has a current PB Ratio of 22.60. The current PB Ratio is 22.60 and 680.7% above the Biotechnology industry median of 2.90. TC BioPharm (Holdings)'s overall GF Score™ is 17/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For TC BioPharm (Holdings) (FRA:T0U), the current PB Ratio is 22.60 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TC BioPharm (Holdings) Business Description

Address Maxim 1, 2 Parklands Way, Holytown, Motherwell, Scotland, GBR, ML1 4WR
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.
17GF Score

Get the complete analysis for FRA:T0U

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€132.00
Price